PRTC PureTech Health plc: Forward P/S Multiple
The forward P/S history of PureTech Health plc (PRTC) demonstrates the current valuation of the asset, where 90.80 shows the value of this parameter. This trend reflects the creation of biotech subsidiaries and the monetization of patents. The episodic nature of gains from the sale of stakes complicates short-term cash flow planning. Long-term margin growth relies on the successful completion of clinical trials within incubated companies.
Comprehensive metric breakdowns and analytics for PureTech Group (PRTC)
- current price and projected stock value:
- company stock capitalization data:
- issuer book value statistics:
- debt level and financial liquidity data:
Total Debt to Capital PureTech Health plc|PRTC - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital PureTech Health plc|PRTC - Company Cumulative Debt|Debts to Book Capitalization PureTech Group|PRTC - Company Long-Term Debts|Company Short-Term Debt PureTech Health|Quick Liquidity Indicator puretechhealth.com
- financial results and valuation multiples details:
PRTC - Profit After Payment of Taxes|Projected Future Earnings PureTech Health plc|PRTC - Company Value to Net Income|Projected Price to Earnings PureTech Corp|PRTC - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PureTech Group|PRTC - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months PureTech Health|PRTC - Earnings per share for the last twelve months|Quarterly EPS earnings growth puretechhealth.com|PRTC - Net earnings per share growth this year|Net earnings per share growth forecast for next year PureTech Health plc
- company sales and revenue statistics:
Initial company analysis:PureTech Health PRTC
The specifics of the PureTech Health (PRTC) biopharmaceutical ecosystem and its startup portfolio require valuation based on expected revenue, as current sales often fail to reflect the potential of technological convergence. By analyzing the forward P/S ratio, an investor compares the company's market value with future income streams, which allows for the determination of asset overvaluation and the risk of a long-term price correction.
Competitors of PureTech Health plc
Forward P/S Multiple BRK-A (Berkshire Hathaway)|Johnson and Johnson (JNJ) - Market Cap to Future Revenue Ratio|General Electric Co. - Forward P/S Multiple|3M Corporation (MMM) - Forward Price-to-Revenue Multiple|ITW: Forward P/S Multiple|orix.co.jp - Forward Price to Sales|Forward Price-to-Revenue Multiple DOV|PAGP: Forward Price to Sales|Forward P/S Multiple BZ|LBRDA (Liberty Broadband Corp.) - Forward Price to Sales|Forward P/S Multiple SWX (Southwest Gas Holdings)|cswindustrials.com (CSW) - Market Cap to Future Revenue Ratio|Griffon - Forward P/S Multiple|OTTR - Forward P/S Multiple|brookfield.com (BBUC) - Price-to-Projected Revenue Ratio|PAM (Pampa Energia SA) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple MDU|PCH (potlatchdeltic.com) - Price to Expected Revenue Ratio|Forward P/S Multiple CSAN|NWL (Newell Brands Inc) - Forward Price to Sales|Brookfield Business Partners - Forward Price-to-Revenue Multiple|Forward Price to Sales KEN|FORTY - Price-to-Projected Revenue Ratio|Future Price to Revenue TRS|Ziff Davis (ZD) - Price-to-Projected Revenue Ratio|SPB (spectrumbrands.com) - Price-to-Projected Revenue Ratio|TIPT (Tiptree Corp) - Forward P/S Multiple|Forward Price-to-Revenue Multiple SOS Information Technology (SOS)|Price-to-Projected Revenue Ratio Resolute Holdings (RHLD)|CODI: Future Price to Revenue|Price-to-Projected Revenue Ratio Valhi VHI|Forward Price to Sales TRC|UPXI: Forward Price-to-Revenue Multiple|Concrete Pumping Holdings - Price to Expected Revenue Ratio|BW: Forward P/S Multiple|Forward Price-to-Revenue Multiple NL Industries|MERC (Mercer International Inc) - Forward P/S Multiple|LGO: Forward Price to Sales|Price-to-Projected Revenue Ratio Great Elm Group, Inc. (GEG)|VATE - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Marygold Companies Inc MGLD|Star Equity Holdings Inc - Price-to-Projected Revenue Ratio|United Guardian - Forward P/S Multiple|HTCR (HeartCore Enterprises) - Market Cap to Projected Revenue|NXPL: Forward P/S Multiple|MWYN - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Planet Green Holdings Corp|Market Cap to Projected Revenue DSS (Document Security Systems)|Forward P/S Multiple ARBB|newconceptenergy.com (GBR) - Projected Price to Revenue|Price-to-Projected Revenue Ratio Ucommune International Limited UK|HE (Hawaiian Electric Industries, Inc.) - Future Price to Revenue|AULT: Forward Price-to-Revenue Multiple|CSWI - Forward P/S Multiple|ideanomics.com (IDEX) - Price-to-Projected Revenue Ratio|Jewett-Cameron Trading Company - Forward Price to Sales|SPLP (Steel Partners Holdings, L.P.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Vector Group Limited VGR|Forward Price-to-Revenue Multiple VINO (Gaucho Group Holdings)|Price to Expected Revenue Ratio RHLDV
